These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 33581999)
1. Recurrent hyperhemolytic transfusion reaction in myelodysplastic syndrome- A case based approach. Augustine M; Murugesan M; Nair CK; Raghavan V; Nayanar SK Transfus Apher Sci; 2021 Jun; 60(3):103073. PubMed ID: 33581999 [TBL] [Abstract][Full Text] [Related]
2. Hyperhemolytic Transfusion Reaction in Non-Hemoglobinopathy Patients and Terminal Complement Pathway Activation: Case Series and Review of the Literature. Cid J; Fernández J; Palomo M; Blasco M; Bailó N; Diaz-Ricart M; Lozano M Transfus Med Rev; 2020 Jul; 34(3):172-177. PubMed ID: 32703665 [TBL] [Abstract][Full Text] [Related]
3. Hyperhemolysis syndrome in a patient without a hemoglobinopathy, unresponsive to treatment with eculizumab. Gupta S; Fenves A; Nance ST; Sykes DB; Dzik WS Transfusion; 2015 Mar; 55(3):623-8. PubMed ID: 25257194 [TBL] [Abstract][Full Text] [Related]
10. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease. Talano JA; Hillery CA; Gottschall JL; Baylerian DM; Scott JP Pediatrics; 2003 Jun; 111(6 Pt 1):e661-5. PubMed ID: 12777582 [TBL] [Abstract][Full Text] [Related]
11. Treatment with intravenous immunoglobulin and steroids may correct severe anemia in hyperhemolytic transfusion reactions: case report and literature review. Win N; Sinha S; Lee E; Mills W Transfus Med Rev; 2010 Jan; 24(1):64-7. PubMed ID: 19962576 [TBL] [Abstract][Full Text] [Related]
12. A novel method for the laboratory workup of anaphylactic transfusion reactions in haptoglobin-deficient patients. Thoren KL; Avecilla ST; Klimek V; Goss C Transfusion; 2020 Apr; 60(4):682-687. PubMed ID: 31975382 [TBL] [Abstract][Full Text] [Related]
13. Adverse impact of hyperferritinemia and transfusion dependency on treatment success in myelodysplastic syndrome. Cakar MK; Yegin ZA; Baysal NA; Altındal S; Pamukçuoğlu M; Celik B; Yenicesu I Transfus Apher Sci; 2013 Jun; 48(3):397-401. PubMed ID: 23619324 [TBL] [Abstract][Full Text] [Related]
14. Effect of premedication and other factors on the occurrence of acute transfusion reactions in dogs. Bruce JA; Kriese-Anderson L; Bruce AM; Pittman JR J Vet Emerg Crit Care (San Antonio); 2015; 25(5):620-30. PubMed ID: 26109490 [TBL] [Abstract][Full Text] [Related]
15. Analysis of complications after blood components' transfusions. Timler D; Klepaczka J; Kasielska-Trojan A; Bogusiak K Pol Przegl Chir; 2015 Apr; 87(4):166-73. PubMed ID: 26146115 [TBL] [Abstract][Full Text] [Related]
16. Red blood cell alloimmunization in 184 patients with myeloid neoplasms treated with azacitidine - A retrospective single center experience. Leisch M; Weiss L; Lindlbauer N; Jungbauer C; Egle A; Rohde E; Greil R; Grabmer C; Pleyer L Leuk Res; 2017 Aug; 59():12-19. PubMed ID: 28535394 [TBL] [Abstract][Full Text] [Related]
17. Anti-N and anti-Do Unnikrishnan A; Pelletier JPR; Bari S; Zumberg M; Shahmohamadi A; Spiess BD; Michael MJ; Harris N; Harrell D; Mandernach MW Transfusion; 2019 Jun; 59(6):1907-1910. PubMed ID: 30768787 [TBL] [Abstract][Full Text] [Related]
18. Hyperhemolytic transfusion reaction attributable to anti-Fy3 in a patient with sickle cell disease. Reyes MA; Illoh OC Immunohematology; 2008; 24(2):45-51. PubMed ID: 19852130 [TBL] [Abstract][Full Text] [Related]